Insulet Corporation (PODD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Insulet Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Insulet Corporation (PODD) has returned -26.18% so far this year and -20.09% over the past 12 months. Looking at the last ten years, PODD has achieved an annualized return of 20.13%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since May 15, 2007, PODD's average daily return is +0.10%, while the average monthly return is +2.06%. At this rate, your investment would double in approximately 2.8 years.

Historically, 55% of months were positive and 45% were negative. The best month was Dec 2008 with a return of +57.9%, while the worst month was Oct 2008 at -59.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 4 months.

On a daily basis, PODD closed higher 52% of trading days. The best single day was Mar 12, 2009 with a return of +32.6%, while the worst single day was Mar 6, 2009 at -34.3%.

Insulet Corporation has an annualized alpha of 16.53%, beta of 1.13, and R² of 0.20 versus S&P 500 Index. Calculated based on daily prices since May 16, 2007.

• This stock captured 155.94% of S&P 500 Index gains and 120.30% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.20 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

PODD ranks 20 for risk / return — in the bottom 20% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Insulet Corporation (PODD) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Insulet Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Insulet Corporation was 90.28%, occurring on Mar 11, 2009. Recovery took 1046 trading sessions.

The current Insulet Corporation drawdown is 40.52%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Insulet Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Insulet Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.